MEGA BOMBS! Deadly GMO Parasites are the mRNA Vectors: Patent Review with Dr. Young & Dr. Love

Dr. Robert Young and Dr. Ariyana Love (ND) join forces once again to show you patent receipts and scientific evidence that deadly parasites are being genetically modified and used as vectors for the Covid-19 Democide.

In part one of this bombshell presentation, Dr. Young revealed that over 90% of his patients are infested with these deadly parasites. We also provided some simple solutions in Part 1.

See Part 1 here:

https://rumble.com/v1lutfq-dr.-robert-young-and-dr.-ariyana-love-discuss-the-root-causes-of-disease.html

Follow Dr. Young's work here:
https://www.drrobertyoung.com/

Contribute to the Research here:
https://www.givesendgo.com/research

Follow Dr. Ariyana Love's work here:
https://ambassadorlove.wordpress.com

Follow Dr. Love on Telegram:
https://t.me/DrAriyanaLove

References:

VAXX CONTENTS

1.
https://patents.justia.com/patent/7612043

2. https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-018-2648-4

Overview of components in the mRNA export pathway in mammals and Toxoplasma gondii. a mRNA export in mammalian cells. During gene expression, THO is recruited co-transcriptionally (1), followed by recruitment of the adaptors UAP56 and REF/Aly, which trigger TREX assembly and deposition along the transcript (2). Components of the exon junction complex (EJC) are also bound to mRNA during splicing (3). Once bound to mRNA, TREX recruits the NXF1:NXT1 heterodimer, causing a conformation change in NXF1 and allowing exposure of its RNA-binding domain for interaction with mRNA. This process is promoted by the co-adaptor CHTOP and the adaptor REF/Aly (4). TREX-2 is another complex that interacts with NXF1 and nucleoporins to dock mRNA ribonucleoprotein (mRNP) to the nuclear pore (5). Both TREX and TREX-2 pathways promote mRNP export via NXF1:NXT1. The adaptors are released from mRNP during passage through the nuclear pore complex (NPC) (6). On the cytoplasmic side of the NPC, DDX19 is activated by Gle1 and Isnp6 to trigger the release of NXF1 from mRNA (7), and some components are recycled back to the nucleus (8). The EJC is dissociated from mRNA when translation is initiated (9). b Overview of conserved components identified in Toxoplasma gondii by bioinformatic searches. Conserved components are colored; non-conserved components are shown in gray. A divergent REF/Aly homolog has been identified [75], and TgZNF2 is proposed to be a functional homolog of the export receptor

3. Moderna Patent - https://patents.google.com/patent/WO2021159040A2

4. VAXX CONTENTS

SEQ ID NO: 1

Found in Pfizer

Seq ID No: 1 patent - Birbright Institute
https://patents.justia.com/patent/20130216569

SEQ ID NO: 2

Found in Moderna, Pfizer and
Novavax

Seq ID No: 2
https://patents.justia.com/patent/7612043

mRNA export in the apicomplexan parasite Toxoplasma gondii: emerging divergent components of a crucial pathway (Graph of parasites entering cell) – Plasmodium falciparum, Toxoplasma gondii and Trypanosoma cruzi
https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-018-2648-4

VAXX PATENTS

Moderna
https://patents.google.com/patent/WO2021159040A2

Pfizer
https://patents.google.com/patent/WO2021213945A1

Novavax
https://patents.google.com/patent/US20210228709A1

Justia (https://patents.justia.com/patent/2013021656
9)
US Patent Application for VACCINE Patent Application (Application #20130216569 issued August 22, 2013) - Justia Patents Search